Biliary Atresia in Children: Update on Disease Mechanism, Therapies, and Patient Outcomes.

Swati Antala, Sarah A Taylor

Journal: Clinics in liver disease 2022;26(3):341-354

PMID: 35868678

Abstract

Biliary atresia is a rare disease but remains the most common indication for pediatric liver transplantation as there are no effective medical therapies to slow progression after diagnosis. Variable contribution of genetic, immune, and environmental factors contributes to disease heterogeneity among patients with biliary atresia. Developing a deeper understanding of the disease mechanism will help to develop targeted medical therapies and improve patient outcomes.

Copyright © 2022 Elsevier Inc. All rights reserved.

Address: Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Ann and Robert H Lurie Children's Hospital of Chicago, 225 East Chicago Avenue, Box 65, Chicago, IL 60611, USA.; Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Ann and Robert H Lurie Children's Hospital of Chicago, 225 East Chicago Avenue, Box 65, Chicago, IL 60611, USA. Electronic address: [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.